Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02013557 · ClinicalTrials.gov registry record · NA

Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes

A NA study, sponsored by University of South Florida.

Terminated
Registry status
NA
Development phase
57
Enrollment target

NCT02013557 is a NA study that was terminated before completion, run by University of South Florida. The registered enrollment target is 57 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02013557, a NA study, was terminated before completion, sponsored by University of South Florida.

TERMINATED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery. Study Design: Prospective randomized control trial Hypothesis: Gestational diabetics will be significantly more likely to follow up with their postpartum screening for diabetes if they receive text-message reminders to set up their lab appointment compared to those who receive usual care.

Interventions

  • BEHAVIORAL Text-message reminder

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2014-01
Est. Completion 2015-12
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT02013557

The ClinicalTrials.gov registry entry for NCT02013557 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Text-message reminder is the first listed.

NCT02013557 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02013557 about?

NCT02013557 is a clinical study titled "Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes". Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery. Study Design: Prospective randomized control trial Hypothesis: Gestational diabetics will be significantly more likely to foll...

What is the current status of trial NCT02013557?

This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2014-01. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02013557?

The interventions under investigation include: Text-message reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT02013557?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.